A novel method of treatment of Kala Azar using medicament comprising of antileishmanial amphotericin B encapsulated in leishmaniacidal cationic liposome.
Benefits
The drug-loaded liposomes have enhanced efficacy as antileishmanial agents and provide improved therapeutic index as compared to the free drug; Safe and stable. Immense therapeutic potential.
Accessibility Controls